APA (7th ed.) Citation

Bossi, P., Merlano, M., Ghi, M., Rinaldi, G., Caponigro, F., Morelli, F., . . . Licitra, L. (2019). 1140P - A single-arm, open-label, multicenter, phase IIIb clinical trial with nivolumab in subjects with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck. Annals of oncology, 30, v463. https://doi.org/10.1093/annonc/mdz252.032

Chicago Style (17th ed.) Citation

Bossi, P., et al. "1140P - A Single-arm, Open-label, Multicenter, Phase IIIb Clinical Trial with Nivolumab in Subjects with Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck." Annals of Oncology 30 (2019): v463. https://doi.org/10.1093/annonc/mdz252.032.

MLA (9th ed.) Citation

Bossi, P., et al. "1140P - A Single-arm, Open-label, Multicenter, Phase IIIb Clinical Trial with Nivolumab in Subjects with Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck." Annals of Oncology, vol. 30, 2019, p. v463, https://doi.org/10.1093/annonc/mdz252.032.